Registration still open for unique personalized cancer medicine event
Publication date: 30 June 2010
Author: kdm communications limited
Tagged with: Agilent Technologies, GE Healthcare, Life Technologies, WIN Symposium
Registration for the second annual WIN Symposium on personalized cancer medicine is still open, with a preferential rate available until the 4th of July. This unique event, to be held on the 7th to 9th of July 2010 in the Palais des Congrès, Paris, will offer an unprecedented opportunity to discuss the latest advances in tailored cancer medicine, focusing on early diagnosis and rapid translation of scientific discoveries to clinical practice.
Supported by media partner Nature Publishing Group and technology founders Agilent Technologies, GE Healthcare and Life Technologies, the WIN Symposium aims to develop greater collaboration in the scientific community, both academic and industrial. The WIN Symposium’s innovative approach has been endorsed by numerous academic institutions and oncology organizations around the world – including the American Society of Clinical Oncology (ASCO), the European Society for Medical Oncology (ESMO) and the Organisation of European Cancer Institutes (OECI) – as well as sponsorship from the National Breast Cancer Foundation, Inc. and sanofi-aventis.
The program of the WIN Symposium will be dedicated to early diagnosis, personalized medicine and the future of oncology care, and will give participants the chance to discuss this complex issue with key opinion leaders, in an open and interactive forum. The WIN Symposium has been accredited with 17 ESMO-MORA category 1 points.
Register now to attend this unique event.
Email newsletter
If you enjoyed this article sign-up to receive our bi-weekly email newsletter:
Latest news
- FDA approves JANUMET® XR (sitagliptin and metformin HCl extended-release) for type 2 diabetes (2 February 2012)
- AstraZeneca to cut a further 7,300 jobs (2 February 2012)
- FDA approves Novartis drug Glivec® label (1 February 2012)
- Private and public partners unite to combat 10 neglected tropical diseases by 2020 (30 January 2012)
- Novartis extends commitment to help achieve final elimination of leprosy (30 January 2012)
PAT supplement
This free to view PAT supplement is sponsored by Sartorius, Extrel, ABB, Bruker Optics and FOSS NIRSystems:
Company directory
ABB Analytical Measurements | Almac | BD Diagnostics | Bio-Optronics, Inc. | bioMérieux | BioTek Instruments, Inc. | Bruker Daltonik GmbH | CAMO Software AS | CI Precision | Cisbio Bioassays | Colder Products Company | Expo Technologies, LLC. | Freeman Technology | GE Analytical Instruments | HACH LANGE GMBH | HORIBA Scientific | Hudson Robotics, Inc. | Natoli Engineering Company, Inc. | Peter Huber Kältemaschinenbau GmbH | Randox Pharma Services | Rapid Micro Biosystems | Smithers Viscient | Synbiosis | Syngene | Watson-Marlow Pumps Group |
Login to access exclusive content